SPA Pricing Education, Analytics & Decision Making Tools Webinar Series

Tag: Drug Pricing

Boots Says It’s “Truly Sorry” For How It Responded To A Campaign To Lower The Price Of The Morning-After Pill | BuzzFeed

Boots Says It’s “Truly Sorry” For How It Responded To A Campaign To Lower The Price Of The Morning-After Pill | BuzzFeed

Boots has apologised for its handling of criticism over pricing of the morning-after pill and said it will work towards bring down the price of such drugs. In a recent letter to the British Pregnancy Advisory Service (BPAS), Boots’s chief pharmacist Marc Donovan said lowering the price of emergency contraception could lead the firm “to […]

Aralez Pharmaceuticals Inc. (NASDAQ:ARLZ) Spikes on Zontivity Launch | Stock News Union

Aralez Pharmaceuticals Inc. (NASDAQ:ARLZ) Spikes on Zontivity Launch | Stock News Union

From Arlez Pharmaceuticals press release: “We are encouraged by the early data following the launch of Zontivity® and we will continue to monitor prescribing data closely over the next few quarters to determine whether this trend continues,” Aralez Pharmaceutical’s in a statement. Sales Force Reductions Aralez has carried out a 32% U.S sales force reduction […]

Novartis price dilemma over $21,000 drug | The Austrailian

Novartis price dilemma over $21,000 drug | The Austrailian

Novartis recently discovered that a drug it sells for a group of very rare diseases could be used to treat a much more common ailment. There is just one problem: its $US16,000-per-dose ($A21,000) price tag. The drug, called ACZ885, is already sold under the brand name Ilaris for certain rare inflammatory disorders affecting a very […]

The price dilemma over a $16,000 drug | Fox Business

The price dilemma over a $16,000 drug | Fox Business

If the drug does pan out with regulators, Novartis would have to drastically cut its price to make it competitive with other cardiovascular drugs. That would mean jettisoning a small, but reliable, revenue stream on an uncertain bet that the drug could become a top seller as a cardiovascular medicine. “They’ve got a bit of […]

Why did these generic drugs’ prices jump as much as 85%? | MarketWatch

Why did these generic drugs’ prices jump as much as 85%? | MarketWatch

On June 13, as members of a Senate health panel gathered to discuss the rising cost of prescription drugs, the prices of 14 common medications were increased by some 20% to 85%. The affected drugs would appear to be unlikely candidates for price hikes. All were generic drugs, which lack patent protection and therefore tend […]

EU tests limits of drug pricing freedom in landmark probe | Reuters

EU tests limits of drug pricing freedom in landmark probe | Reuters

The first ever EU antitrust probe into excessive drug pricing is taking the European pharmaceuticals industry into uncharted territory, unnerving some companies and lawyers worried about the reach of market intervention. It comes as drugmakers face global pressure over the high cost of prescription medicines, with particular anger focused on makers of older generic products […]

After months of taunts and tantrums, Martin Shkreli’s fraud trial gets underway | ENDPOINTS NEWS

After months of taunts and tantrums, Martin Shkreli’s fraud trial gets underway | ENDPOINTS NEWS

Shkreli didn’t become infamous in biotech for starting or buying Retrophin or KaloBios, both now free of any entanglements. He owes his notoriety to Turing, a company which he started, bagging a cheap, old generic for $50 million and then hiking the price more than 5000%. In the process, he became a lightning rod for […]

New Pain Drug Likely To Face Price Challenges From Payers | Forbes

New Pain Drug Likely To Face Price Challenges From Payers | Forbes

In certain ways, CNTX-4975 is reminiscent of the Epi-Pen. The active component of the later is epinephrine which, like capsaicin, is a drug that’s been known for decades. It’s the injector device, however, and not the drug, that drives Mylan’s proprietary position – and price – for the Epi-Pen. Similarly, the STRATI technology is what […]

Insulin is too expensive for many of my patients. It doesn’t have to be. | The Washington Post

Insulin is too expensive for many of my patients. It doesn’t have to be. | The Washington Post

A recent paper in the Journal of the American Medical Association found that insulin nearly tripled in cost from 2002 to 2013. A lawsuit filed in January accuses pharmaceutical companies of price collusion for allegedly raising insulin prices repeatedly and in lockstep to match their competitors. Prices have gotten so bad that the American Diabetes Association recently launched an […]

Trump’s new policy to tackle sky-high drug prices makes sense — sort of | Vox

Trump’s new policy to tackle sky-high drug prices makes sense — sort of | Vox

Today, the Trump administration revealed its most comprehensive policy direction on tackling the problem of prescription drug prices — in a brief blog post by the Food and Drug Administration chief Scott Gottlieb. Gottlieb outlined the administration’s “Drug Competition Action Plan,” which will focus on increasing the competition among cheaper (off patent) generic drugs. “Innovation […]